Abiraterone Krka Evrópusambandið - íslenska - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateron asetat - blöðruhálskirtli - innkirtla meðferð - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Evrópusambandið - íslenska - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hinsveiflur og heilahimnubólur og hliðstæður - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Astrozol Filmuhúðuð tafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

astrozol filmuhúðuð tafla 1 mg

williams & halls ehf - anastrozolum inn - filmuhúðuð tafla - 1 mg

Candpress Comp Tafla 16 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

candpress comp tafla 16 mg/12,5 mg

teva b.v.* - candesartanum cílexetíl; hydrochlorothiazide - tafla - 16 mg/12,5 mg

Daivobet Hlaup 50 míkróg/g /0,5 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

daivobet hlaup 50 míkróg/g /0,5 mg/g

leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - hlaup - 50 míkróg/g /0,5 mg/g

Daivobet Smyrsli 50 míkrog/g og 0,5 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

daivobet smyrsli 50 míkrog/g og 0,5 mg/g

leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - smyrsli - 50 míkrog/g og 0,5 mg/g